Welcome to our dedicated page for Jackson Acquisition Co Ii news (Ticker: JACS), a resource for investors and traders seeking the latest updates and insights on Jackson Acquisition Co Ii stock.
Jackson Acquisition Company II news centers on its role as a SPAC formed to pursue an initial business combination and on corporate-status developments tied to its NYSE-listed securities. Company updates describe its blank-check structure, stated healthcare services and healthcare technology search focus, and exchange-listing compliance matters.
Recent disclosure has included a New York Stock Exchange notice related to the minimum public stockholder requirement and the company’s plan process under NYSE procedures. News about JACS is therefore tied less to operating results and more to SPAC governance, listing status, shareholder-base requirements and business-combination positioning.
Jackson Acquisition Company II (NYSE:JACS) received a written notice from the New York Stock Exchange on February 6, 2026 finding noncompliance with the Listing Rule requiring a minimum of 300 public stockholders.
The company has 45 days to file a plan to regain compliance within 18 months. The Notice does not have an immediate effect on trading; securities will remain listed during the 18-month cure period if the NYSE approves the plan, subject to ongoing NYSE review and other listing standards.
Jackson Acquisition Company II (NYSE: JACS.U) announced that starting January 30, 2025, holders of units from its December 11, 2024 IPO can separately trade Class A ordinary shares and rights. Each unit comprises one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share upon completing an initial business combination.
The separated Class A ordinary shares and rights will trade on the NYSE under symbols 'JACS' and 'JACS.R' respectively, while unseparated units will continue trading as 'JACS.U'. Unit holders must contact Continental Stock Transfer & Trust Company through their brokers to separate units. The securities registration statement was declared effective by the SEC on December 9, 2024.